Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Post-transplantation lymphoproliferative disorder after haematopoietic stem cell transplantation.

Annals of hematology - 1 Apr 2021

Pegoraro Francesco, Favre Claudio

Abstract excerpt

Post-transplantation lymphoproliferative disorder (PTLD) is a severe complication of haematopoietic stem cell transplantation (HSCT), occurring in a setting of immune suppression and dysregulation. The disease is in most cases driven by the reactivation of the Epstein-Barr virus (EBV), which induces B cell proliferation through different pathomechanisms. Beyond EBV, many factors, variably dependent on...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epstein-Barr Virus Infections
Share to Graft vs Host Disease
Share to Herpesvirus 4, Human

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Immunocompromised Host

Share to Lymphoproliferative Disorders

Share to Rituximab

Share to Transplantation Conditioning

Share to Virus Activation

Source

Identifiers

PMID: 33547921
DOI: 10.1007/s00277-021-04433-y

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Post-transplantation lymphoproliferative disorder after haematopoietic stem cell transplantation.PMID 33547921Read ↗

Epstein-Barr virus-associated posttransplant lymphoproliferative disorders: new insights in pathogenesis, classification and treatmentSemantic proximity Read ↗

Posttransplant Lymphoproliferative DisordersSemantic proximity Read ↗

Epstein‐Barr virus post‐transplant lymphoproliferative disease ( PTLD ) after hematopoietic stem cell transplantationSemantic proximity Read ↗

Clinical and pathological features of post-transplant lymphoproliferative disorders (PTLD).Semantic proximity Read ↗

Post-transplant lymphoproliferative disorders: a morphologic, phenotypic and genotypic spectrum of disease.Semantic proximity Read ↗

Posttransplant Lymphoproliferative Disorder Following Kidney Transplantation: A Review.Semantic proximity Read ↗

Post-transplant lymphoproliferative disorders: molecular basis of disease histogenesis and pathogenesis.Semantic proximity Read ↗

Clinical Practice Recommendations on Indication and Timing of Hematopoietic Cell Transplantation in Mature T Cell and NK/T Cell Lymphomas: An International Collaborative Effort on Behalf of the Guidelines Committee of the American Society for Blood and Marrow TransplantationSemantic proximity Read ↗

Risk factors for Epstein-Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantationSemantic proximity Read ↗

Molecular pathogenesis of B-cell posttransplant lymphoproliferative disorder: what do we know so far?Semantic proximity Read ↗

Infectious Complications and Mortality in Post-Transplant Lymphoproliferative Disorder Following Solid Organ Transplantation: Experiences of 10 Years in a Single CenterSemantic proximity Read ↗

Tabelecleucel for allogeneic haematopoietic stem-cell or solid organ transplant recipients with Epstein-Barr virus-positive post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE): a phase 3, multicentre, open-label trial.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.